Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ryanodine receptor type 2 (RyR2) is the primary calcium release channel located on the sarcoplasmic reticulum (SR) of cardiomyocytes. It mediates calcium-induced calcium release, a crucial process in excitation-contraction coupling, where a small influx of calcium triggers a much larger release of calcium from the SR, initiating muscle contraction. Dysregulation of RyR2 is implicated in various cardiac pathologies, making it a significant therapeutic target.
Modulation of calcium release from sarcoplasmic reticulum
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ryanodine Receptor 2 (RyR2) (RyR2).